Search hospitals > Colorado > Denver
Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center
Claim this profileDenver, Colorado 80218
Global Leader in Tumors
Global Leader in Lymphoma
Conducts research for Leukemia
Conducts research for Recurrence
Conducts research for Neuroblastoma
110 reported clinical trials
1 medical researcher
Summary
Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center is a medical facility located in Denver, Colorado. This center is recognized for care of Tumors, Lymphoma, Leukemia, Recurrence, Neuroblastoma and other specialties. Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center is involved with conducting 110 clinical trials across 269 conditions. There are 1 research doctors associated with this hospital, such as Jennifer J. Clark.Area of expertise
1Tumors
Global LeaderStage IV
Stage I
Stage II
2Lymphoma
Global LeaderStage IV
Stage II
Stage III
Top PIs
Clinical Trials running at Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center
Osteosarcoma
Langerhans Cell Histiocytosis
Germ Cell Tumors
Rhabdomyosarcoma
Non-Hodgkin's Lymphoma
Brain Tumor
Neuroectodermal Tumors
Rhabdoid Tumor
Hepatoblastoma
Ewing Sarcoma
Thoracotomy vs Thoracoscopy
for Metastatic Osteosarcoma
This phase III trial compares the effect of open thoracic surgery (thoracotomy) to thoracoscopic surgery (video-assisted thoracoscopic surgery or VATS) in treating patients with osteosarcoma that has spread to the lung (pulmonary metastases). Open thoracic surgery is a type of surgery done through a single larger incision (like a large cut) that goes between the ribs, opens up the chest, and removes the cancer. Thoracoscopy is a type of chest surgery where the doctor makes several small incisions and uses a small camera to help with removing the cancer. This trial is being done evaluate the two different surgery methods for patients with osteosarcoma that has spread to the lung to find out which is better.
Recruiting2 awards Phase 37 criteria
Genetic Testing-Directed Therapy
for Pediatric Cancer
This Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which no standard treatment exists that has been shown to prolong survival. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more from treatment which targets their tumor's particular genetic mutation, and may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.
Recruiting1 award Phase 214 criteria
Ensartinib
for Cancer
This phase II Pediatric MATCH treatment trial studies how well ensartinib works in treating patients with solid tumors, non-Hodgkin lymphoma, or histiocytic disorders with ALK or ROS1 genomic alterations that have come back (recurrent) or does not respond to treatment (refractory) and may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). Ensartinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Recruiting1 award Phase 217 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center?
Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center is a medical facility located in Denver, Colorado. This center is recognized for care of Tumors, Lymphoma, Leukemia, Recurrence, Neuroblastoma and other specialties. Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center is involved with conducting 110 clinical trials across 269 conditions. There are 1 research doctors associated with this hospital, such as Jennifer J. Clark.